<!doctype html><html lang=en-us><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=generator content="Wowchemy 5.1.0 for Hugo"><meta name=author content="Ali Emami"><meta name=description content="The dual-hormone artificial pancreas is an emerging technology to treat type 1 diabetes (T1D). It consists of a glucose sensor, infusion pumps, and a dosing algorithm that directs hormonal delivery. Preclinical optimization of dosing algorithms using computer simulations has the potential to accelerate the pace of development for this technology. However, current simulation environments consider glucose regulation models that either do not include glucagon action submodels or include submodels that were proposed without comparison to other candidate models. We consider here nine candidate models of glucagon action featuring a number of possible characteristics: insulin-independent glucagon action, insulin/glucagon ratio effect on hepatic glucose production, insulin-dependent suppression of glucagon action, and the effect of rate of change of glucagon. To assess the models, we use measurements of plasma insulin, plasma glucagon, and endogenous glucose production collected from experiments involving eight subjects with T1D who receive four subcutaneous glucagon boluses. We estimate each model's parameters using a Bayesian approach, and the models are contrasted based on the deviance information criterion. The model achieving the best fit features insulin-dependent suppression of glucagon action and incorporates effects of both glucagon levels and its rate of change."><link rel=alternate hreflang=en-us href=https://aemami.ca/publication/emami-2016-modeling/><link rel=preconnect href=https://fonts.gstatic.com crossorigin><meta name=theme-color content="#4caf50"><script src=https://aemami.ca/js/mathjax-config.js></script>
<link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/academicons/1.9.0/css/academicons.min.css integrity="sha512-W4yqoT1+8NLkinBLBZko+dFB2ZbHsYLDdr50VElllRcNt2Q4/GSs6u71UHKxB7S6JEMCp5Ve4xjh3eGQl/HRvg==" crossorigin=anonymous><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.14.0/css/all.min.css integrity="sha256-FMvZuGapsJLjouA6k7Eo2lusoAX9i0ShlWFG6qt7SLc=" crossorigin=anonymous><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.2.0/styles/github.min.css crossorigin=anonymous title=hl-light media=print onload='this.media="all"'><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.2.0/styles/dracula.min.css crossorigin=anonymous title=hl-dark media=print onload='this.media="all"' disabled><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.7.1/leaflet.min.css integrity="sha512-1xoFisiGdy9nvho8EgXuXvnpR5GAMSjFwp40gSRE3NwdUdIMIKuPa7bqoUhLD0O/5tPNhteAsE5XyyMi5reQVA==" crossorigin=anonymous media=print onload='this.media="all"'><script src=https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml.js integrity crossorigin=anonymous async></script>
<link rel=preload as=style href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap"><link rel=stylesheet href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap" media=print onload='this.media="all"'><link rel=stylesheet href=https://aemami.ca/css/wowchemy.308a404b1aa9ff8f25e050213e19f23e.css><script async src="https://www.googletagmanager.com/gtag/js?id=G-X6NGTTS8T0"></script>
<script>window.dataLayer=window.dataLayer||[];function gtag(){dataLayer.push(arguments)}function trackOutboundLink(e,t){gtag("event","click",{event_category:"outbound",event_label:e,transport_type:"beacon",event_callback:function(){t!=="_blank"&&(document.location=e)}}),console.debug("Outbound link clicked: "+e)}function onClickCallback(e){if(e.target.tagName!=="A"||e.target.host===window.location.host)return;trackOutboundLink(e.target,e.target.getAttribute("target"))}gtag("js",new Date),gtag("config","G-X6NGTTS8T0",{}),gtag("set",{cookie_flags:"SameSite=None;Secure"}),document.addEventListener("click",onClickCallback,!1)</script><link rel=manifest href=https://aemami.ca/index.webmanifest><link rel=icon type=image/png href=https://aemami.ca/media/icon_hu29bb0f8250f761abddc65535b755b381_104744_32x32_fill_lanczos_center_3.png><link rel=apple-touch-icon type=image/png href=https://aemami.ca/media/icon_hu29bb0f8250f761abddc65535b755b381_104744_180x180_fill_lanczos_center_3.png><link rel=canonical href=https://aemami.ca/publication/emami-2016-modeling/><meta property="twitter:card" content="summary"><meta property="og:site_name" content="Ali Emami"><meta property="og:url" content="https://aemami.ca/publication/emami-2016-modeling/"><meta property="og:title" content="Modeling glucagon action in patients with type 1 diabetes | Ali Emami"><meta property="og:description" content="The dual-hormone artificial pancreas is an emerging technology to treat type 1 diabetes (T1D). It consists of a glucose sensor, infusion pumps, and a dosing algorithm that directs hormonal delivery. Preclinical optimization of dosing algorithms using computer simulations has the potential to accelerate the pace of development for this technology. However, current simulation environments consider glucose regulation models that either do not include glucagon action submodels or include submodels that were proposed without comparison to other candidate models. We consider here nine candidate models of glucagon action featuring a number of possible characteristics: insulin-independent glucagon action, insulin/glucagon ratio effect on hepatic glucose production, insulin-dependent suppression of glucagon action, and the effect of rate of change of glucagon. To assess the models, we use measurements of plasma insulin, plasma glucagon, and endogenous glucose production collected from experiments involving eight subjects with T1D who receive four subcutaneous glucagon boluses. We estimate each model's parameters using a Bayesian approach, and the models are contrasted based on the deviance information criterion. The model achieving the best fit features insulin-dependent suppression of glucagon action and incorporates effects of both glucagon levels and its rate of change."><meta property="og:image" content="https://aemami.ca/media/icon_hu29bb0f8250f761abddc65535b755b381_104744_512x512_fill_lanczos_center_3.png"><meta property="twitter:image" content="https://aemami.ca/media/icon_hu29bb0f8250f761abddc65535b755b381_104744_512x512_fill_lanczos_center_3.png"><meta property="og:locale" content="en-us"><meta property="article:published_time" content="2024-06-28T23:12:02+00:00"><meta property="article:modified_time" content="2024-06-29T23:32:00-04:00"><script type=application/ld+json>{"@context":"https://schema.org","@type":"Article","mainEntityOfPage":{"@type":"WebPage","@id":"https://aemami.ca/publication/emami-2016-modeling/"},"headline":"Modeling glucagon action in patients with type 1 diabetes","datePublished":"2024-06-28T23:12:02Z","dateModified":"2024-06-29T23:32:00-04:00","author":{"@type":"Person","name":"Ali Emami"},"publisher":{"@type":"Organization","name":"Brock University","logo":{"@type":"ImageObject","url":"https://aemami.ca/media/icon_hu29bb0f8250f761abddc65535b755b381_104744_192x192_fill_lanczos_center_3.png"}},"description":"The dual-hormone artificial pancreas is an emerging technology to treat type 1 diabetes (T1D). It consists of a glucose sensor, infusion pumps, and a dosing algorithm that directs hormonal delivery. Preclinical optimization of dosing algorithms using computer simulations has the potential to accelerate the pace of development for this technology. However, current simulation environments consider glucose regulation models that either do not include glucagon action submodels or include submodels that were proposed without comparison to other candidate models. We consider here nine candidate models of glucagon action featuring a number of possible characteristics: insulin-independent glucagon action, insulin/glucagon ratio effect on hepatic glucose production, insulin-dependent suppression of glucagon action, and the effect of rate of change of glucagon. To assess the models, we use measurements of plasma insulin, plasma glucagon, and endogenous glucose production collected from experiments involving eight subjects with T1D who receive four subcutaneous glucagon boluses. We estimate each model's parameters using a Bayesian approach, and the models are contrasted based on the deviance information criterion. The model achieving the best fit features insulin-dependent suppression of glucagon action and incorporates effects of both glucagon levels and its rate of change."}</script><title>Modeling glucagon action in patients with type 1 diabetes | Ali Emami</title></head><body id=top data-spy=scroll data-offset=70 data-target=#TableOfContents class=page-wrapper data-wc-page-id=f3ad9a1026485007a9c0b569c27c61d1><script src=https://aemami.ca/js/wowchemy-init.min.c4b90dff1cebe730b9c3b416b2576fc5.js></script><aside class=search-modal id=search><div class=container><section class=search-header><div class="row no-gutters justify-content-between mb-3"><div class=col-6><h1>Search</h1></div><div class="col-6 col-search-close"><a class=js-search href=# aria-label=Close><i class="fas fa-times-circle text-muted" aria-hidden=true></i></a></div></div><div id=search-box><input name=q id=search-query placeholder=Search... autocapitalize=off autocomplete=off autocorrect=off spellcheck=false type=search class=form-control aria-label=Search...></div></section><section class=section-search-results><div id=search-hits></div></section></div></aside><div class=page-header><nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id=navbar-main><div class=container-xl><div class="d-none d-lg-inline-flex"><a class=navbar-brand href=https://aemami.ca/>Ali Emami</a></div><button type=button class=navbar-toggler data-toggle=collapse data-target=#navbar-content aria-controls=navbar aria-expanded=false aria-label="Toggle navigation">
<span><i class="fas fa-bars"></i></span></button><div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none"><a class=navbar-brand href=https://aemami.ca/>Ali Emami</a></div><div class="navbar-collapse main-menu-item collapse justify-content-start" id=navbar-content><ul class="navbar-nav d-md-inline-flex"><li class=nav-item><a class=nav-link href=https://aemami.ca/#about><span>Home</span></a></li><li class=nav-item><a class=nav-link href=https://aemami.ca/group/><span>Group</span></a></li><li class=nav-item><a class="nav-link active" href=https://aemami.ca/publication><span>Publications</span></a></li><li class=nav-item><a class=nav-link href=https://aemami.ca/course/><span>Courses</span></a></li><li class=nav-item><a class=nav-link href=https://aemami.ca/talk/><span>Talks</span></a></li><li class=nav-item><a class=nav-link href=https://aemami.ca/#contact><span>Contact</span></a></li><li class=nav-item><a class=nav-link href=https://aemami.ca/uploads/resume.pdf><span>CV</span></a></li></ul></div><ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2"><li class=nav-item><a class="nav-link js-search" href=# aria-label=Search><i class="fas fa-search" aria-hidden=true></i></a></li><li class="nav-item dropdown theme-dropdown"><a href=# class=nav-link data-toggle=dropdown aria-haspopup=true aria-label="Display preferences"><i class="fas fa-moon" aria-hidden=true></i></a><div class=dropdown-menu><a href=# class="dropdown-item js-set-theme-light"><span>Light</span></a>
<a href=# class="dropdown-item js-set-theme-dark"><span>Dark</span></a>
<a href=# class="dropdown-item js-set-theme-auto"><span>Automatic</span></a></div></li></ul></div></nav></div><div class=page-body><div class=pub><div class="article-container pt-3"><h1>Modeling glucagon action in patients with type 1 diabetes</h1><div class=article-metadata><div><span>Ali Emami</span>, <span>Joseph El Youssef</span>, <span>Remi Rabasa-Lhoret</span>, <span>Joelle Pineau</span>, <span>Jessica R Castle</span>, <span>Ahmad Haidar</span></div><span class=article-date>January 2016</span></div><div class="btn-links mb-3"><a href=# class="btn btn-outline-primary btn-page-header js-cite-modal" data-filename=/publication/emami-2016-modeling/cite.bib>Cite</a>
<a class="btn btn-outline-primary btn-page-header" href=https://pubmed.ncbi.nlm.nih.gov/27448377/ target=_blank rel=noopener>PubMed</a></div></div><div class=article-container><h3>Abstract</h3><p class=pub-abstract>The dual-hormone artificial pancreas is an emerging technology to treat type 1 diabetes (T1D). It consists of a glucose sensor, infusion pumps, and a dosing algorithm that directs hormonal delivery. Preclinical optimization of dosing algorithms using computer simulations has the potential to accelerate the pace of development for this technology. However, current simulation environments consider glucose regulation models that either do not include glucagon action submodels or include submodels that were proposed without comparison to other candidate models. We consider here nine candidate models of glucagon action featuring a number of possible characteristics: insulin-independent glucagon action, insulin/glucagon ratio effect on hepatic glucose production, insulin-dependent suppression of glucagon action, and the effect of rate of change of glucagon. To assess the models, we use measurements of plasma insulin, plasma glucagon, and endogenous glucose production collected from experiments involving eight subjects with T1D who receive four subcutaneous glucagon boluses. We estimate each model&rsquo;s parameters using a Bayesian approach, and the models are contrasted based on the deviance information criterion. The model achieving the best fit features insulin-dependent suppression of glucagon action and incorporates effects of both glucagon levels and its rate of change.</p><div class=row><div class=col-md-1></div><div class=col-md-10><div class=row><div class="col-12 col-md-3 pub-row-heading">Type</div><div class="col-12 col-md-9"><a href=https://aemami.ca/publication/#2>Journal article</a></div></div></div><div class=col-md-1></div></div><div class="d-md-none space-below"></div><div class=row><div class=col-md-1></div><div class=col-md-10><div class=row><div class="col-12 col-md-3 pub-row-heading">Publication</div><div class="col-12 col-md-9"><em>IEEE journal of biomedical and health informatics</em></div></div></div><div class=col-md-1></div></div><div class="d-md-none space-below"></div><div class=space-below></div><div class=article-style></div><div class=share-box aria-hidden=true><ul class=share><li><a href="https://twitter.com/intent/tweet?url=https://aemami.ca/publication/emami-2016-modeling/&amp;text=Modeling%20glucagon%20action%20in%20patients%20with%20type%201%20diabetes" target=_blank rel=noopener class=share-btn-twitter><i class="fab fa-twitter"></i></a></li><li><a href="https://www.facebook.com/sharer.php?u=https://aemami.ca/publication/emami-2016-modeling/&amp;t=Modeling%20glucagon%20action%20in%20patients%20with%20type%201%20diabetes" target=_blank rel=noopener class=share-btn-facebook><i class="fab fa-facebook"></i></a></li><li><a href="mailto:?subject=Modeling%20glucagon%20action%20in%20patients%20with%20type%201%20diabetes&amp;body=https://aemami.ca/publication/emami-2016-modeling/" target=_blank rel=noopener class=share-btn-email><i class="fas fa-envelope"></i></a></li><li><a href="https://www.linkedin.com/shareArticle?url=https://aemami.ca/publication/emami-2016-modeling/&amp;title=Modeling%20glucagon%20action%20in%20patients%20with%20type%201%20diabetes" target=_blank rel=noopener class=share-btn-linkedin><i class="fab fa-linkedin-in"></i></a></li><li><a href="whatsapp://send?text=Modeling%20glucagon%20action%20in%20patients%20with%20type%201%20diabetes%20https://aemami.ca/publication/emami-2016-modeling/" target=_blank rel=noopener class=share-btn-whatsapp><i class="fab fa-whatsapp"></i></a></li><li><a href="https://service.weibo.com/share/share.php?url=https://aemami.ca/publication/emami-2016-modeling/&amp;title=Modeling%20glucagon%20action%20in%20patients%20with%20type%201%20diabetes" target=_blank rel=noopener class=share-btn-weibo><i class="fab fa-weibo"></i></a></li></ul></div></div></div></div><div class=page-footer><div class=container><footer class=site-footer><p class=powered-by><a href=https://aemami.ca/terms/></a></p><p class=powered-by>© 2024 Ali Emami</p></footer></div></div><div id=modal class="modal fade" role=dialog><div class=modal-dialog><div class=modal-content><div class=modal-header><h5 class=modal-title>Cite</h5><button type=button class=close data-dismiss=modal aria-label=Close>
<span aria-hidden=true>&#215;</span></button></div><div class=modal-body><pre><code class="tex hljs"></code></pre></div><div class=modal-footer><a class="btn btn-outline-primary my-1 js-copy-cite" href=# target=_blank><i class="fas fa-copy"></i> Copy</a>
<a class="btn btn-outline-primary my-1 js-download-cite" href=# target=_blank><i class="fas fa-download"></i> Download</a><div id=modal-error></div></div></div></div></div><script src=https://cdnjs.cloudflare.com/ajax/libs/jquery/3.5.1/jquery.min.js integrity="sha256-9/aliU8dGd2tb6OSsuzixeV4y/faTqgFtohetphbbj0=" crossorigin=anonymous></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/instant.page/5.1.0/instantpage.min.js integrity="sha512-1+qUtKoh9XZW7j+6LhRMAyOrgSQKenQ4mluTR+cvxXjP1Z54RxZuzstR/H9kgPXQsVB8IW7DMDFUJpzLjvhGSQ==" crossorigin=anonymous></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin=anonymous></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin=anonymous></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.2.0/highlight.min.js integrity="sha512-TDKKr+IvoqZnPzc3l35hdjpHD0m+b2EC2SrLEgKDRWpxf2rFCxemkgvJ5kfU48ip+Y+m2XVKyOCD85ybtlZDmw==" crossorigin=anonymous></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.2.0/languages/bash.min.js></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.2.0/languages/cpp.min.js></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.2.0/languages/julia.min.js></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.2.0/languages/python.min.js></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.7.1/leaflet.min.js integrity="sha512-SeiQaaDh73yrb56sTW/RgVdi/mMqNeM2oBwubFHagc5BkixSpP1fvqF47mKzPGWYSSy4RwbBunrJBQ4Co8fRWA==" crossorigin=anonymous></script>
<script id=search-hit-fuse-template type=text/x-template>
        <div class="search-hit" id="summary-{{key}}">
          <div class="search-hit-content">
            <div class="search-hit-name">
              <a href="{{relpermalink}}">{{title}}</a>
              <div class="article-metadata search-hit-type">{{type}}</div>
              <p class="search-hit-description">{{snippet}}</p>
            </div>
          </div>
        </div>
      </script><script src=https://cdnjs.cloudflare.com/ajax/libs/fuse.js/3.2.1/fuse.min.js integrity="sha256-VzgmKYmhsGNNN4Ph1kMW+BjoYJM2jV5i4IlFoeZA9XI=" crossorigin=anonymous></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin=anonymous></script>
<script src=https://aemami.ca/js/bootstrap.bundle.min.6aed84840afc03ab4d5750157f69c120.js></script>
<script src=https://aemami.ca/en/js/wowchemy.min.4ea9cc8d09c5c158656ac1a804743b34.js></script></body></html>